Dr. Sanjay Maraboyina
Claim this profileUniversity of Arkansas for Medical Sciences
Studies Prostate Cancer
Studies Lung Cancer
9 reported clinical trials
37 drugs studied
Area of expertise
1Prostate Cancer
2Lung Cancer
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Sanjay Maraboyina is currently running
Stereotactic Radiation + Immunotherapy
for Kidney Cancer
This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has spread to other places in the body (metastatic). Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses of radiation over a shorter period and cause less damage to normal tissue. Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, avelumab, and pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving SABR in combination with standard of care immunotherapy may help shrink or stabilize the cancer in patients with renal cell cancer.
Recruiting1 award Phase 221 criteria
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
More about Sanjay Maraboyina
Clinical Trial Related2 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Sanjay Maraboyina has experience with
- Stereotactic Body Radiation Therapy
- Atezolizumab
- Apalutamide
- Degarelix
- Histrelin
- Bicalutamide
Breakdown of trials Sanjay Maraboyina has run
Prostate Cancer
Lung Cancer
Prostate Adenocarcinoma
Non-Small Cell Lung Cancer
Gastroesophageal Junction Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sanjay Maraboyina specialize in?
Sanjay Maraboyina focuses on Prostate Cancer and Lung Cancer. In particular, much of their work with Prostate Cancer has involved treating patients, or patients who are undergoing treatment.
Is Sanjay Maraboyina currently recruiting for clinical trials?
Yes, Sanjay Maraboyina is currently recruiting for 5 clinical trials in Little Rock Arkansas. If you're interested in participating, you should apply.
Are there any treatments that Sanjay Maraboyina has studied deeply?
Yes, Sanjay Maraboyina has studied treatments such as Stereotactic Body Radiation Therapy, Atezolizumab, Apalutamide.
What is the best way to schedule an appointment with Sanjay Maraboyina?
Apply for one of the trials that Sanjay Maraboyina is conducting.
What is the office address of Sanjay Maraboyina?
The office of Sanjay Maraboyina is located at: University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205 United States. This is the address for their practice at the University of Arkansas for Medical Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.